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Summary. We assessed the biological activity of a crude extract, a mixture of several fractions, and a pure compound obtained from Piper 
ovatum Vahl against promastigote and amastigote forms of Leishmania amazonensis. The medicinal plant P. ovatum is used popularly as 
an anesthetic and anti-inflammatory. This study included the extraction process and bioassay-guided fractionation by the adsorption chro-
matography and Sephadex LH-20 method. A progressive increase in the antileishmanial effect was observed in the course of fractionation. 
The 50% inhibitory concentration (IC50) for dichloromethane-ethyl
 acetate (1:1 v/v) fraction was 2.1 µg/ml and 24 µg/ml; mixture of 
piperovatine: piperlongumune (2:3) 0.9 µg/ml and 24 µg/ml; piperovatine (1) 9.5 µg/ml and 10 µg/ml; and piperlonguminine (2) 2.5 µg/ml 
and 9.0 µg/ml, for promastigote and amastigote forms, respectively. Cytotoxicity analysis indicated that these toxic concentrations were 
much higher for J774G8 macrophages and Vero cells than for the protozoans. The mixture of piperovatine: piperlongumune (2:3) showed 
important antiprotozoal activity against the amastigote and promastigote forms of L. amazonensis, and it produced morphological changes 
in promastigotes and amastigotes at 0.9 µg/ml and 24 µg/ml (50% growth inhibition concentration), respectively, including intense cytoplas-
mic vacuolization, mitochondrial swelling, and mitochondrial damage, as revealed by transmission electron microscopy. 
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INTRODUCTION 
Leishmaniasis is an insect-borne protozoan infection 
that affects an estimated 12 million people worldwide, 
causing significant morbidity and mortality in Africa, 
Asia and Latin America (WHO 2001). Pentavalent an-
timonials are the first-line treatments, but their irregu-
lar effectiveness makes them sometimes disappointing 
because of antimonial resistance and relapse follow-
ing Amphotericin B therapy. Second-line drugs, such 
as Amphotericin B, are more toxic, and Amphotericin 
B’s lipid formulation is too expensive for routine use 
in underdeveloped countries (Murray 2001). There is 
at present no effective vaccine for humans (Handman 
2001). Several new alkylphosphocholine derivatives 
with amide or ester bonds in the alkyl chain have been 
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synthesized that show antileishmanial activity. More re-
cently, these compounds have shown great promise in 
the treatment of parasitic infections, in particular those 
caused by Leishmania spp., and n-hexadecylphospho-
choline (miltefosine) has been approved in several 
countries for clinical use in the treatment of leishmani-
asis (Obando  et al. 2007).
The family Piperaceae contains 2000 species (Wan-
ke  et al. 2006, Quijano-Abril  et al. 2006) and Piper 
is the most important genus of the family. Species of 
Piper, which are widely distributed in the tropics and 
subtropics, are used medicinally in various ways. Plants 
of the genus Piper are well known in Indian Ayurvedic 
medicine for their medicinal properties, and also in folk 
medicine of Latin America and the West Indies (Parmar 
et al. 1997). The leaves of two species of the family 
Piperaceae (Piper hispidum Sw. and Piper strigosum 
Trel.) show good leishmanicidal activity, with IC50 < 
10 g/ml against amastigotes (Estevez et al. 2007). The 
biological activity of the crude extract and several frac-
tions obtained from Piper regnellii var. pallescens was 
assessed against the growth of promastigote forms of 
Leishmania amazonensis (Nakamuara et al. 2006). 
Piper ovatum Vahl, an herbaceous plant found 
throughout Brazil, is popularly known as “joão burandi” 
or “anestésica,” and is used in traditional medicine for 
the treatment of inflammation and as an analgesic (Cor-
rea 1984). The hydroalcoholic extract, fractions, and a 
mixture of piperovatine and piperlonguminine in a pro-
portion of 2:3 obtained from P. ovatum were assayed for 
anti-inflammatory activity by means of carrageenan-in-
duced pleurisy in rats and croton oil-induced ear edema 
in mice (Rodrigues Silva et al. 2008). Piperovatine iso-
lated from Ottonia martina Miq. showed satisfactory 
activity against Cylindrocladium spathulatum, Fusarium 
oxysporum, Colletotrichum acutatum, and Rhizoctonia 
sp., by inhibiting the germination process (Cunico 2006). 
Other activities of piperovatine are still little known. It 
can stimulate intense salivation, has an anesthetic effect 
in mice, and is toxic to fish (Makapugay et al. 1983, Mc-
Ferren and Rodriguez 1998). Piperovatine isolated from 
Piper piscicatorum is a potent stimulator of neuronal 
intracellular calcium, and is considered clinically to be 
a local anesthetic (McFerren et al. 2002). Extraction of 
the roots of P. piscatorum with MeOH and subsequent 
bioassay-guided fractionation using the guppy Girardina 
guppii yielded the active piperovatine (McFerren and 
Rodriguez 1998). The amide constituent (piperlongumi-
nine) from the fruit of Piper chaba caused adipogenesis 
of 3T3-L1 cells (Zangh et al. 2008).
Piper species such as Piper kadsura and Piper 
boehmeriifolium var. tonkinense are used to treat in-
flammatory diseases in traditional Chinese medicine. 
The n-hexane extract of this species inhibits the for-
mation of leukotrienes, and prostaglandin synthesis 
and amides were identified in the n-hexane extract by 
analytical investigation (Stohr et al. 2001). In the pres-
ent study, amides including piperovatine and piperlon-
guminine obtained from this species were purified by 
bioassay-guided chemical fractionation and identified. 
Their antiproliferative effects on the amastigote and 
promastigote forms of Leishmania amazonensis and the 
ultrastructural changes that they produced in amastigote 
and promastigote forms were evaluated. In addition, the 




The NMR spectra were obtained in Bruker DRX-400 (8.4 T) 
and VARIAN GEMINI 300 (7.05T) spectrometers, using deuterated 
solvent, TMS as the internal standard, and a constant temperature of 
298K. Low-resolution electrospray data were acquired in the nega-
tive ion mode, using a Micromass Quattro-LC instrument. Silica gel 
60 (70–230 and 230–400 mesh); TLC: silica gel plates F254 (0.25 
mm thickness).
HPLC analysis
The hydroalcoholic extract of Piper ovatum leaves (HE) was 
analyzed by HPLC using a Shimadzu HPLC system consisting of an 
LC-10AD solvent delivery pump, and an SPD-10Avp UV detector. 
The system was controlled by CLASS LC-10 software. The column 
was Metasil ODS (150 × 4.6 mm; 5 µm particle size). Elution was 
done in step isocratic mode, with CH3CN/H2O 60-40 (0–12 min.) at 
a flow rate of 1.0 ml min.-1 and the eluted compounds were moni-
tored at 280 nm. The HE extract (1 mg) was dissolved in 1 mL of 
CH3CN/H2O (60–40), filtered in a Millex
® filter, and injected (20 
µL) into the HPLC system.
Plant material
Piper ovatum Vahl leaves were collected in November 2004, in 
Monte Formoso, state of Minas Gerais, Brazil, and were identified 
by Dra. Elsie Franklin Guimarães. A voucher specimen was depos-
ited in the herbarium of the Department of Botany, University of 
Maringá (HUM 10.621).
Plant extraction and purification
Leaves were dried at room temperature, and powdered (100 g). 
The extract was prepared by exhaustive maceration in ethanol:wa-
ter (9:1 v/v) at room temperature, filtered, and concentrated under 
vacuum at 40°C to obtain an hydroalcoholic extract (HE), which 
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was lyophilized, yielding 23 g.  The hydroalcoholic extract (14 g) 
was chromatographed in a vacuum silica-gel column and eluted with 
gradients of hexane, dichloromethane-ethyl acetate (1:1 v/v), ethyl 
acetate and methanol, which afforded F1 (2.19 g), F2 (3.83 g), F3 
(2.91 g) and F4 (3.60 g).  The dichloromethane-ethyl acetate fraction 
F2 (3.1 g) was rechromatographed on a silica gel 60 (70–230 mesh) 
column chromatograph eluted with gradients of hexane, hexane/di-
chloromethane (98:2, 95:5, 90:10, 80:20 and 50:50 v/v), dichloro-
methane, dichloromethane/ethyl acetate (98:2, 95:5, 90:10, 80:20 and 
50:50 v/v), Ethyl acetate and methanol afforded 108 fractions. Frac-
tions 23–38 (258.2 mg) were identified as a mixture of piperovatine 
and piperlonguminine (M). This subfraction was rechromatographed 
on a Sephadex LH 20, and the column chromatograph was eluted with 
ethyl acetate, obtaining 50 fractions. Fractions 15–32 (20 mg) and 
42–50 (40 mg) were isolated and identified as piperovatine (1) and 
piperlonguminine (2) respectively, by analyses of spectral data of 1H 
and 13C and by comparison of data from the literature (McFerren and 
Rodriguez 1998; Wu et al. 2004).  
Preparation of stock solutions
The crude extracts and fractions were dissolved in DMSO prior 
to adding them to the appropriate culture medium. The final concen-
tration of DMSO in the test medium never exceeded 0.5%, a con-
centration which has no effect on the growth of parasites. The stock 
solution of Amphotericin B (AMPB) (Cristália Produtos Químicos 
Farmacêuticos Ltda, Itapira, São Paulo, Brazil) was prepared in 
phosphate-buffered saline.
Parasites
Promastigote forms of L. amazonensis (MHOM/BR/75/Josefa), 
originally isolated from a human case of diffuse cutaneous leish-
maniasis, were maintained by weekly transfers in Warren’s medium 
(brain-heart infusion plus haemin and folic acid) supplemented with 
10% heat-inactivated fetal bovine serum (FBS) (Gibco Invitrogen 
Corporation, New York, U.S.A.) at 25oC in a tissue flask.
Axenic amastigote forms of L. amazonensis were obtained by 
in vitro transformation of infective promastigotes (Ueda-Nakamura 
et al., 2001), and maintained by weekly transfers in Schneider’s In-
sect medium (Sigma Chemical Co., St. Louis, Missouri, USA) at 
pH 4.6, supplemented with 20% heat-inactivated FBS at 32oC in 
a tissue flask.
Cells
J774G8 murine macrophages were maintained in tissue flasks 
in RPMI 1640 medium (Gibco Invitrogen Corporation, New York, 
USA) with sodium bicarbonate and L-glutamine and supplemented 
with 10% fetal bovine serum at 37oC in a 5% CO2-air mixture. 
Antileishmanial activity
Promastigote forms of L. amazonensis (1 × 106 parasites/ml) 
were added to a 24-well plate in Warren’s medium supplemented 
with 10% inactivated FBS containing different concentration (of 
the hydroalcoholic extract, hexane dichloromethane-ethyl acetate 
(1:1 v/v), ethyl acetate, methanol fractions (were performed with 
1000 – 1 μg/ml); mixture amides and pure isolated compounds (at 
concentrations 100 – 1 μg/ml), incubated at 25ºC for 72 h. Axenic 
amastigotes were incubated in Schneider’s Insect medium supple-
mented with 20% inactivated FBS containing the crude extract, frac-
tions, mixture amides or pure compounds at 32ºC, for 72 h. The 
cell density for each treatment was determined daily in a hemocy-
tometer (Improved Double Neubauer) with an optical microscope. 
In all tests, 0.5% dimethyl sulfoxide (DMSO; Sigma Chemical Co., 
St. Louis, Missouri), a concentration that was used to dissolve the 
highest dose of the compounds but that had no effect on cell prolif-
eration, and medium alone were used as controls. Each experiment 
was performed triplicate on three different occasions. The 50% In-
hibitory Concentration (IC50) and the 90% Inhibitory Concentration 
(IC90) were determined by logarithm regression analysis of the data 
obtained, used with the positive control, Amphotericin B.
Cytotoxicity assay
A suspension of 5 × 104 J774G8 macrophage cells in RPMI-
1640 medium or Vero cells in DMEM supplemented with 10% FBS 
was added to each well in 96-well microplates. The plates were in-
cubated in a 5% CO2-air mixture at 37
oC to obtain confluent growth 
of the cells. After 24 h, the medium was removed and several con-
centrations of purified compound and fractions (0.1 to 1000 µg/ml) 
were added to each well containing the cells, and the plates were 
incubated for 48 h. The nonadherent cells were removed by washing 
with the medium, and the adhered cells were fixed with 50 µl/well 
of 10% trichloroacetic acid at 4oC for 1 h; after that, the well plates 
were washed with water, and 50 µl/well of sulforhodamine B (0.4% 
w/v in 1% acetic acid solution was added); the microplate was then 
maintained at 4oC for 30 min. Next, the sulforhodamine B was re-
moved and the microplate was washed 5 times with 1% acetic acid, 
then 150 µl/well of 10 mM unbuffered Tris-base solution (Sigma) 
was added, and this was homogenized for 15 min. The absorbance 
of each individual well, minus the blank value, was calculated auto-
matically. Each experiment was performed in triplicate on three dif-
ferent occasions, and the percentage of viable cells was calculated in 
relation to controls cultured in medium alone. The 50% Cytotoxic-
ity Concentration (CC50) was determined by logarithm regression 
analysis of the data. 
Ultrastructural analysis
Promastigote and amastigote forms of L. amazonensis treated 
with the isolated compound (IC50 and IC90), 0.5% DMSO, or me-
dium alone were collected by centrifugation after 72 h incubation, 
washed in 0.01 M phosphate-buffered saline at pH 7.2, and fixed in 
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer at 4oC. The 
cells were postfixed in a solution containing 1% osmium tetroxide, 
5 mM CaCl2 and 0.8% potassium ferrocyanide in 0.1 M cacodyl-
ate buffer, washed in the same buffer, dehydrated in acetone, and 
embedded in Epon® resin. Ultrathin sections obtained in a Reichert 
Ultracut E ultramicrotome were stained with uranyl acetate and lead 
citrate and examined in a Zeiss 900 transmission electron micro-
scope (TEM).
Statistical analysis
All experiments were performed in triplicate on three different 
occasions. The means and standard deviations of at least three ex-
periments were determined. The differences between mean values 
obtained for experimental groups were analyzed by means of Stu-
dent’s-t test. P values of 0.05 or less were regarded as significant.
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RESULTS 
Structure elucidation
The leaves of Piper ovatum afforded a hydroalco-
holic extract, and this extract was chromatographed 
in a vacuum silica-gel column, which yielded hexane, 
dichloromethane-ethyl acetate (1:1, v/v), ethyl acetate 
and methanol fractions. The dichloromethane-ethyl ac-
etate fraction showed the highest antiprotozoal activity 
against the amastigote and promastigote forms of L. 
amazonensis. Fractionation of this fraction led to purifi-
cation of the compounds 1 and 2, which were identified 
by analysis of their spectroscopic data and comparison 
with literature (McFerren and Rodriguez 1998, Wu et 
al. 2004). By analysis of spectral data of the C13 signal, 
it was determined that piperlonguminine was the major-
ity substance in the mixture (2:3) (Rodrigues-Silva et 
al. 2008). Figure 1 shows the chromatographic profile 
of the crude extract. Two major peaks indicate pipero-
vatine at a retention time of 3.9 min., and piperlongumi-
nine at 4.65 min. (Fig. 1). 
Antileishmanial activity
The effects of the hydroalcoholic extract from P. 
ovatum leaves on the growth of L. amazonensis were 
tested. This extract inhibited growth of the promastigote 
and amastigote forms, with IC50 of 60.0 and 78.5 μg/
ml, respectively, after 72 h of incubation. The IC50 val-
ues of these fractions are listed in Table 1. The dichloro-
methane-ethyl acetate fraction showed the most activity, 
with IC50 of 2.1 μg/ml and 24 μg/ml for promastigote 
and amastigote forms, respectively, after 72 h of incuba-
tion. Fractionation of the dichloromethane-ethyl acetate 
fraction led to purification of the compounds piperova-
tine and piperlonguminine and a mixture of compounds 
1 and 2, which showed IC50 values of 9.5 and 10 μg/
ml; 2.5 μg/ml and 9 μg/ml; and 0.5 μg/ml and 24 μg/
ml against promastigote and amastigote forms, respec-
tively, after 72 h of treatment. The dilution agent (0.5% 
DMSO) had no effect on the parasite proliferation and 
cellular morphology. Amphotericin B showed IC50 of 
0.058 and 0.231 μg/ml against promastigote and amas-
tigote forms, respectively, after 72 h of treatment.
Cytotoxicity assay
J774G8 murine macrophages and Vero cells were 
treated with increasing concentrations of the hydroal-
coholic extract, hexane, dichloromethane-ethyl acetate, 
ethyl acetate, methanol fractions or the pure isolated 
compounds piperovatine and piperlonguminine and 
a mixture of both (2:3), to evaluate the safety of this 
Fig. 1. Chromatogram of the hydroalcoholic extract of Piper ovatum leaves [piperovatine (1) and piperlonguminine (2)]. Chromatographic 
conditions: Metasil ODS column; mobile phase: acetonitrile/water (60:40, v/v) with 2% acetic acid; flow-rate: 1.0 ml/min; room tempera-
ture; detection: 280 nm.
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compound for mammalian cells After 48 h of treatment, 
cell viability was checked by a sulforhodamine B colo-
rimetric assay. The CC50 values of piperovatine, piper-
longuminine and the mixture of both (2:3) on macro-
phages and Vero cells were 41.8 and > 1000 μg/ml; 326 
and 839 μg/ml; and 53.7 and 679.5 μg/ml, respectively. 
In order to evaluate the effectiveness of the fractions 
and pure compounds, the selectivity index (SI) was de-
termined (IC50 for J774G8 macrophages or Vero cells/ 
IC50 for protozoans). When this value is greater than 1, 
the compound is more selective for activity against par-
asites than macrophages or Vero cells; when the value 
is less than 1, the compound is more selective for activ-
ity against macrophages or Vero cells. All fractions and 
pure compounds were more selective against parasites 
than mammalian cells, as seen in Table 1.
Transmission electron microscopy
Promastigote and amastigote forms of treated and un-
treated L. amazonensis were examined by transmission 
electron microscopy to assess ultrastructural changes 
caused by the mixture of piperovatine:piperlongumi-
nine (2:3). The promastigote forms were treated at 0.9 
µg/ml (IC50; Fig. 2B – C); and 70 µg/ml (IC90; Fig. 2D. 
Amastigote forms were treated with this mixture at 24 
µg/ml (IC50; Fig. 2F–G). The photomicrographs in Fig. 
2 show parasites with different degrees of damage after 
72 h of incubation. The promastigote and amastigote 
forms treated with IC50 of the mixture showed signifi-
cant morphological alterations: the appearance of mul-
tiple cytoplasmic vacuolization (Fig. 2C)  and consider-
able mitochondrial swelling (Fig. 2B, C, F, G). These 
features indicate damage and significant changes in this 
organelle. The promastigote forms treated with IC90 of 
the mixture showed significant morphological altera-
tions, as well as the appearance of multiple cytoplasmic 
vacuolization (Fig. 2C, d) and mitochondrial swelling 
(Fig. 2D). No structural changes were observed in un-
treated promastigote and amastigote forms or in cells 
cultured with 0.5% DMSO, which showed normal mor-
phology (Fig. 2A, E).
DISCUSSION
All chemotherapeutic agents for the treatment of 
leishmaniasis have serious side effects, and resistance 
has become a severe problem. Therefore, new drugs are 
urgently required (Croft et al. 2005). Natural products 
have potential in the search for new and selective agents 
for the treatment of important tropical diseases caused 
by protozoans. Alkaloids, terpenes, quinines, and other 
compounds well illustrate the diversity of antiprotozoal 
compounds found in higher plants (Wright and Phillip-
son 1990).
Table 1. Effects of the hydroalcoholic extract (HE); hexane (F1), dichloromethane-ethyl acetate (1:1, v/v) (F2), ethyl acetate (F3), methanol 
(F4) fractions, piperovatine (1), piperlonguminine (2), and mixture of both (M) on the growth of L. amazonensis promastigote forms (PRO), 
amastigote forms (AMA), cytotoxicity to Vero cells (VERO) and Macrophages (MF). 
IC50 (µg/ml) CC50 (µg/ml)
SI
VERO (µg/ml) MF(µg/ml)
PRO AMA VERO MF PRO AMA PRO AMA
HE 60 78.5 520 722 8.7 12.03
F1 4.7 212 72.5 45.1 15.42
F2 2.1 24 39.1 73.0 18.6 3.04 34.8 4.9
F3 101 >1000 >1000 > 9.9 > 9.9
F4 >1000 >1000 >1000
1 9.5 10 41.8 >1000 4.4 4.2 105.3 > 100
2 2.5 9.0 326 839 130 36.22 335.6 93.22
M(1+2) 0.9 24 53.7 679.5 59.66 2.24 755 28.3
IC50 – 50% inhibitory concentration.
CC50 – 50% cytotoxicity concentration.
SI – Selectivity index (CC50/IC50).
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The leaves of two species of a genus of the family 
Piperaceae (Piper hispidum and Piper strigosum) show 
good leishmanicidal activity against amastigotes (Este-
vez et al. 2007). According to Kapil (1993), the amide 
piperine is a potent inhibitor of Leishmania donovani 
promastigotes in vitro. Luize et al. (2005) showed that 
extracts of leaves of P. regnellii possess activity against 
Leishmania amazonensis and Trypanosoma cruzi. Na-
Fig. 2. Transmission electron microscopy of L. amazonensis: promastigote and amastigote forms cultured in medium alone. Promastigote 
Control (A) promastigotes treated with M(1+2) at 0.9 µg/ml (IC50) (B and C); promastigote treated with 70 µg/ml (IC90) (D); amastigote 
control (E); amastigote treated with M(1+2) at 24 µg/ml (IC50) (F and G). (A) amastigotes showing normal morphology; (B, C, and D) 
parasites showing some alterations in the mitochondrion, such as intense swelling; (E) amastigotes showing normal morphology; and (F and 
G) parasites showing some alterations in the mitochondrion, such as intense swelling. (C and D) parasites showing multiple cytoplasmic 
vacuolization; n – nucleus, f – flagellum, fp – flagellar pocket, k – kinetoplast, m – mitochondrion, v – vacuole. Scale: 1 µm.
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kamura et al. (2006) evaluated the antileishmanial ac-
tivity of crude extracts from leaves of P. regnellii var. 
pallescens against promastigotes of L. amazonensis. 
Some bioactive substances have previously been iso-
lated from species of the genus Piper, such as alkalis, 
lignans, neolignans, terpenes, and benzoic acid (Zac-
chino et al. 1997, Park et al. 2002, López et al. 2002, 
Martins et al. 2003).
In the present study, we report antileishmanial activ-
ity of the dichloromethane-ethyl acetate (1:1 v/v) fraction 
obtained by a hydroalcoholic extract of leaves of Piper 
ovatum. This fraction showed IC50 of 2.1 μg/ml and 24 
μg/ml for promastigote and amastigote forms, respec-
tively. Fractionation of the dichloromethane-ethyl acetate 
(1:1 v/v) fraction led to purification of piperovatine and 
piperlongumine-type amides. The dichloromethane-eth-
yl acetate fraction, pure isolated compounds piperovatine 
(1) and piperlonguminine (2), and a mixture of piperova-
tine:piperlonguminine (2:3) showed significant activity 
against promastigote and amastigote forms of L. amazo-
nensis in vitro (Table 1). Our observations suggest that 
the piperovatine and piperlonguminine present in this 
fraction were responsible for the antileishmanial activ-
ity. Both the mixture of two isolated compounds and the 
dichloromethane-ethyl acetate fraction were more active 
than piperovatine (1) and piperlonguminine (2) for pro-
mastigote forms, but the opposite was true for the amas-
tigote forms (Table 1). The difference in activity can be 
observed by pattern substitution of an aromatic ring with 
methoxyl group in piperovatine, and methylenedioxy in 
piperlonguminine. The hydroethanolic extract, fractions, 
mixture, and compounds tested were also evaluated for 
their potential toxic effects in Vero cells and macro-
phages treated with different concentrations; the isolated 
compound showed less cytotoxicity than did the dichlo-
romethane-ethyl acetate (1:1 v/v) fraction on Vero cells 
and macrophages. In vitro tests with macrophages and 
Vero cells showed that all the samples were more selec-
tive for L. amazonensis. This is demonstrated by their SI 
ratio values > 1 (Table 1). 
Toxicity tests for medicinal plants are essential be-
cause of the growing interest in alternative therapies and 
the therapeutic use of natural products (Rates 2001). In 
this context, both the efficacy and the safety of natural 
products require investigation. Significant mitochon-
drial swelling was observed at the ultrastructural level 
when the promastigote and amastigote forms of L. ama-
zonensis were treated for 72 h with IC50 values of a 
mixture of piperovatine:piperlonguminine (2:3) at 0.9 
µg/ml and 24 µg/ml, respectively. Also, intense cyto-
plasmic vacuolization was observed when promastigote 
forms were treated with IC90 values of a mixture of 
piperovatine:piperlonguminine (2:3) at 70 µg/ml for 72 
h. Similar mitochondrial swelling has been reported for 
L. amazonensis treated with 22,26 azasterol, an inhibi-
tor of ergosterol synthesis (Rodrigues et al. 2002), ke-
toconazol and terbinafine (Vannier-Santos et al. 1995), 
and other compounds, derivatives of azasterol (Lorente 
et al. 2004)  which induced a marked alteration. Previ-
ous studies have demonstrated that the presence of er-
gosterol and its analogs is essential for maintenance of 
the normal structural organization of the mitochondrial 
membrane in trypanosomatids (Rodrigues et al. 2001). 
Biochemical studies have shown that, contrary to what 
is known for mammalian cells, there are large amounts 
of endogenous and exogenous sterols in the mitochon-
drial membranes of trypanosomatids (Vannier-Santos et 
al. 1995 and Rodrigues et al. 2001). This indicates that 
the mitochondrion of trypanosomatids is an important 
target in leishmaniasis chemotherapy. Previous studies 
have demonstrated ultrastructural changes in mitochon-
drial morphology of promastigote forms of L. amazo-
nensis treated with different leishmanicidal agents, such 
as purified chalcone from Piper aduncum inflorescenc-
es (Torres-Santos et al. 1999), a purified indole alkaloid 
obtained from the stem of Peschiera australis (Deloren-
zi et al. 2001), eugenol-rich essential oil from Ocimum 
gratissimum (Ueda-Nakamura et al. 2006), and a cou-
marin from Calophyllum brasiliense leaves (Brenzan 
et al. 2007, 2008). No ultrastructural changes were ob-
served in untreated promastigote and amastigote forms, 
or in cells cultured with 0.5% DMSO, which showed a 
normal mitochondrial profile containing the kinetoplast 
(promastigote), and the nucleus and flagellum with nor-
mal morphology (Fig. 2 A and E). The TEM analysis 
contributed significantly to elucidating the mechanism 
of action of the mixture on the parasites, detecting sig-
nificant alterations. However, these studies should be 
expanded. This drug may eventually be shown to have 
good therapeutic potential for the treatment of Ameri-
can cutaneous leishmaniasis.
These results are an exciting advance in the search 
for novel antileishmanial agents from natural sources, 
since they demonstrated significant and important ef-
fects against the intracellular stage of the protozoan. 
This plant showed significant activity against Leishma-
nia pathogens, but further synthesis and in vitro studies 
are indicated in order to validate the results.
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